Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …

The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

Importance Clinical outcomes after curative treatment of resectable pancreatic ductal
adenocarcinoma (PDA) remain suboptimal. To assess the potential of early control of …

PURPOSE In the multicenter, open-label, phase III FOWARC trial, modified infusional
fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus radiotherapy resulted in a higher …

Background The current standard treatment for locally advanced rectal cancer is
neoadjuvant chemoradiotherapy followed by radical surgery, but this approach can lead to …

The 8th edition of the American Joint Committee on Cancer (AJCC) staging of epithelial
cancers of the esophagus and esophagogastric junction (EGJ) presents separate …

Background In locally advanced rectal cancer (LARC), preoperative short-course
radiotherapy (SCRT) with delayed surgery has been shown to be as effective as long-course …

Purpose Total mesorectal excision with fluorouracil-based preoperative chemoradiotherapy
and postoperative chemotherapy is a standard treatment of locally advanced rectal cancer …

Background Locally advanced rectal cancer is usually treated with preoperative
chemoradiation. After chemoradiation and surgery, 15–27% of the patients have no residual …